Editas Medicine, Inc. (0IFK.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 182.82M |
| Enterprise Value | 112.88M |
| P/E Ratio | -3.85 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 7.34 |
| Price/Book Ratio | 4.33 |
| Enterprise/Revenue | 5.75 |
| Enterprise/EBITDA | -3.95 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -1.45 |
| Operating Margin | -1.64 |
AD
Management Effectiveness
| Return On Assets | -0.33 |
| Return On Equity | -1.3 |
Income Statement
| Revenue | 40.52M |
| Revenue/Share | 0.32 |
| Gross Profit | 35.24M |
| EBITDA | -94.06M |
| Net Income | -160.06M |
| Diluted EPS | -1.8 |
Balance Sheet
| Total Cash | 190.2M |
| Total Cash/Share | 1.24 |
| Total Debt | 70.76M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 2.82 |
| Book Value Per Share | 0.55 |
Price History
| 52-Week Change | -6.87 |
| 52-Week High | 3.94 |
| 52-Week Low | 1.67 |
| Moving Average 50 Days | 2.69 |
| Moving Average 200 Days | 2.7 |
Statistics
| Average Volume | 19,438 |
| Shares Outstanding | 92.35M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
